48 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the Nasdaq listing rule regarding board diversity, representing gender diversity of 30% and ethnic diversity of 10%, as presented in the below Board … ) of the Nasdaq listing standards:
As of April 24, 2024
Total Number of Directors
Female
Male
Non-Binary
Did Not
Disclose
Gender
Part I: Gender Identity
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
to the singular shall include the plural and vice versa and references to one gender include any other gender.
19. Expenses. Neither the Company, on the one
F-3
EX-4.4
ufl 46r1q
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-4.3
81whs gkd
5 Aug 21
Shelf registration (foreign)
4:33pm